DKSH Technology acquires Korean life science firm MDxK
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Subscribe To Our Newsletter & Stay Updated